Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of Oral Melphalan Combined With LBH589 for Patients With Relapsed or Refractory Multiple Myeloma (MM)

NCT00743288 is registered in ClinicalTrials.gov with Oncotherapeutics as lead sponsor.

NCT NCT00743288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00743288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of Oral Melphalan Combined With LBH589 for Patients With Relapsed or Refractory Multiple Myeloma (MM)
Lead sponsor
Oncotherapeutics
Phase
Phase 1/2
Overall status
Completed
Start date
July 31, 2008
Completion date
December 31, 2012
Enrollment
40 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma